Study of LW402 in Moderate-to-Severe Atopic Dermatitis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a multi-center, randomized, double blind, placebo-controlled phase 2 study to evaluate the efficacy, safety, PK and PD ofLW402 in patients with moderate-to-severe atopic dermatitis.
Epistemonikos ID: 67ea18037616fc44e0a372ae1f5e69124581f412
First added on: Sep 23, 2025